Fulcrum Therapeutics Inc (FULC)
3.005
-0.32
(-9.49%)
USD |
NASDAQ |
Nov 15, 14:23
Fulcrum Therapeutics Free Cash Flow (Quarterly): 58.90M for June 30, 2024
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 58.90M |
March 31, 2024 | -25.31M |
December 31, 2023 | -23.24M |
September 30, 2023 | -22.97M |
June 30, 2023 | -20.98M |
March 31, 2023 | -24.29M |
December 31, 2022 | -19.81M |
September 30, 2022 | -28.16M |
June 30, 2022 | -28.68M |
March 31, 2022 | -22.35M |
December 31, 2021 | -22.38M |
September 30, 2021 | -22.94M |
June 30, 2021 | -18.39M |
Date | Value |
---|---|
March 31, 2021 | -16.49M |
December 31, 2020 | -20.30M |
September 30, 2020 | -4.597M |
June 30, 2020 | -14.33M |
March 31, 2020 | -15.77M |
December 31, 2019 | -4.603M |
September 30, 2019 | -13.23M |
June 30, 2019 | -12.30M |
March 31, 2019 | -10.21M |
December 31, 2018 | -9.869M |
September 30, 2018 | -5.046M |
June 30, 2018 | -9.213M |
March 31, 2018 | -7.415M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-28.68M
Minimum
Jun 2022
58.90M
Maximum
Jun 2024
-15.62M
Average
-20.98M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
Bioventus Inc | 10.25M |
Arcturus Therapeutics Holdings Inc | -23.84M |
Johnson & Johnson | 5.714B |
Entrada Therapeutics Inc | -24.90M |
Tenon Medical Inc | -2.42M |